William Reichmann, PhD

Senior Director, Head of Clinical Biostatistics
Deciphera Pharmaceuticals, LLC
Waltham, Massachusetts, United States

William Reichmann has over 11 year of experience in the pharmaceutical industry as a biostatistician. He has supported the clinical development of oncology compounds at ARIAD Pharmaceuticals, Takeda Pharmaceuticals, Karyopharm Therapeutics, Anchiano Therapeutics, and Deciphera Pharmaceuticals (current employer). He received his PhD in biostatistics from Boston University in 2012.

Disclosure information not submitted.

Presentation(s):

• Paper 61 - INSIGHT: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF RIPRETINIB VS SUNITINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR PREVIOUSLY TREATED WITH IMATINIB WITH KIT EXON 11+17/18 MUTATIONS

  Saturday, November 4, 2023
  9:00 AM – 10:00 AM